Minerva Neurosciences, Inc. (NERV)
2.32
+0.08
(+3.57%)
USD |
NASDAQ |
Oct 30, 16:00
2.30
-0.02
(-0.86%)
After-Hours: 20:00
Minerva Neurosciences Market Cap : 109.57M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 109.57M |
| October 29, 2026 | 105.79M |
| October 28, 2026 | 104.37M |
| October 27, 2026 | 105.32M |
| October 26, 2026 | 103.90M |
| October 23, 2026 | 108.62M |
| October 22, 2026 | 113.35M |
| October 21, 2026 | 112.87M |
| October 20, 2026 | 119.49M |
| October 19, 2026 | 109.57M |
| October 16, 2026 | 110.98M |
| October 15, 2026 | 114.29M |
| October 14, 2026 | 110.98M |
| October 13, 2026 | 118.78M |
| October 12, 2026 | 136.49M |
| October 09, 2026 | 150.18M |
| October 08, 2026 | 152.07M |
| October 07, 2026 | 154.43M |
| October 06, 2026 | 161.99M |
| October 05, 2026 | 156.79M |
| October 02, 2026 | 154.91M |
| October 01, 2026 | 152.54M |
| September 30, 2026 | 158.21M |
| September 29, 2026 | 158.21M |
| September 28, 2026 | 160.57M |
| Date | Value |
|---|---|
| September 25, 2026 | 160.57M |
| September 24, 2026 | 162.93M |
| September 23, 2026 | 164.82M |
| September 22, 2026 | 179.94M |
| September 21, 2026 | 174.03M |
| September 18, 2026 | 172.85M |
| September 17, 2026 | 163.41M |
| September 16, 2026 | 164.59M |
| September 15, 2026 | 180.88M |
| September 14, 2026 | 189.38M |
| September 11, 2026 | 195.99M |
| September 10, 2026 | 196.47M |
| September 09, 2026 | 194.58M |
| September 08, 2026 | 206.38M |
| September 04, 2026 | 209.22M |
| September 03, 2026 | 221.50M |
| September 02, 2026 | 211.58M |
| September 01, 2026 | 211.58M |
| August 31, 2026 | 215.36M |
| August 28, 2026 | 228.58M |
| August 27, 2026 | 242.28M |
| August 26, 2026 | 256.44M |
| August 25, 2026 | 236.14M |
| August 24, 2026 | 227.16M |
| August 21, 2026 | 228.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Heron Therapeutics, Inc. | 52.61M |
| Tonix Pharmaceuticals Holding Corp. | 85.64M |
| Karyopharm Therapeutics, Inc. | 15.01M |
| Corbus Pharmaceuticals Holdings, Inc. | 78.79M |
| Ocugen, Inc. | 238.25M |
Market Cap Related Metrics
| Price | 2.32 |
| Earnings Yield | -1.24K% |